Luteolin Decreases Fat Accumulation and Extends Lifespan in
Abstract
Targeted regulation of lipid homeostasis through pharmacological interventions is good strategy to combat obesity and prolong lifespan across various organisms. Luteolin derived from edible plants exhibits widespread pharmacological activity. Here, we found that low-lipid phenotype induced by luteolin was transmitted to multigenerational progeny. Intriguingly, we found that DAF-16/FOXO and NHR-49/PPAR-α, along with β-oxidation genes and Δ9 desaturases, were essential for transgenerational fat regulation. Furthermore, H3K4me3 marks fat metabolism genes and enhances their transcription during multigenerational low-lipid inheritance. Importantly, we showed that luteolin activated the nuclear receptor NHR-49/PPAR-α in turn up-regulated transcription of the Δ9 desaturases, leading to increased MUFAs content, which was required for healthspan extension. Furthermore, by screening the classical pathways, we found that luteolin also promoted the healthspan via DAF-16. Our research has shown that luteolin reduces fat and extends lifespan through the same mechanism and luteolin is a potential molecule for weight loss and anti-aging.
The following analysis is generated by AI and may contain errors. It is separate from the authors’ abstract and is not peer review.
Research summary
Luteolin reduces fat accumulation and extends lifespan through mechanisms involving DAF-16/FOXO and NHR-49/PPAR-α. The paper is relevant as it explores pharmacological interventions that target lipid homeostasis and their potential to extend lifespan, addressing fundamental aspects of aging.
Author of this paper? Send a correction.